There is no required downtime
All orders are dispatched directly from our UK warehouse with 24hr tracked shipping
Annual List Review Process Every year, WADA leads the revision process concerning the List, beginning with an initial meeting in January and concluding with the publication of the List by 1 October
About 10% of tirzepatide participants had a heart-rate increase above 20 bpm during escalation, compared with 3% on placebo. A lean Japanese cohort reached +10 to +13 bpm, and 23% of Japanese participants at 15 mg crossed the abnormal-pulse threshold versus 7% of other participants, despite only 17% higher exposure. Lean and East Asian bodies showed greater cardiovascular sensitivity than exposure alone predicted
They will also be transparent about where they source their peptides, using only licensed and accredited compounding pharmacies
Also, go in if you cannot keep fluids down